A2A receptor antogonists for use in the treatment of movement disorders Application EP-2942082-A2 European Patent Office 11 Nov 2015
Antagonists of A2B adenosine receptors for treatment of inflammatory bowel disease Grant US-8193200-B2 United States of America 05 Jun 2012
A2A receptor antogonists for use in the treatment of movement disorders Application EP-2260850-A2 European Patent Office 15 Dec 2010
Methods of treating patients suffering from movement disorders Application EP-2044940-A2 European Patent Office 08 Apr 2009
8-heteroaryl xanthine adenosine A2B receptor antagonists Grant US-7335655-B2 United States of America 26 Feb 2008
8-Heteroaryl xanthine adenosine A2B receptor antagonists Grant US-7205403-B2 United States of America 17 Apr 2007
Substituted 8-phenylxanthines useful as antagonists of A2B adenosine receptors Grant US-6545002-B1 United States of America 08 Apr 2003